미국의 동정맥루 디바이스 시장 규모, 점유율, 동향 분석 : 유형별, 최종 용도별, 부문별 예측(2025-2033년)

U.S. Arteriovenous Fistula Devices Market Summary

The U.S. arteriovenous fistula devices market size was estimated at USD 111.0 million in 2024 and is projected to reach USD 120.0 million by 2033, growing at a CAGR of 0.9% from 2025 to 2033. The growth is attributed to several factors, including the increasing prevalence rate of End-stage Renal Disease (ESRD) and the resulting rise in the number of patients requiring hemodialysis.

The advanced healthcare infrastructure, a high incidence of diabetes & hypertension, and widespread awareness initiatives in the country are expected to drive the market growth. According to 2023 estimates by the Centers for Disease Control and Prevention (CDC), approximately 14% of adults in the U.S. are affected by chronic kidney disease (CKD). Furthermore, the American Kidney Fund reports that approximately 815,000 Americans are currently living with kidney failure, with nearly 555,000 of them undergoing dialysis, highlighting the widespread need for effective treatment solutions.

Due to the critical shortage of kidney donors, the increasing dependence on dialysis underscores the essential role of AVF devices in managing ESRD. The escalating rate of kidney disease is also driving the demand for more advanced and innovative AVF solutions. AV fistulas are preferred for long-term vascular access because of their durability, lower infection rates, and reduced complication risk compared to other access types. These factors are propelling the growth of AVF devices in the U.S.

Two other types of vascular access for hemodialysis, arteriovenous graft (AVG) and central venous catheter (CVC), are the primary substitutes for an arteriovenous fistula. The choice of access has significant clinical and economic implications, directly impacting market dynamics. While AVFs are considered the gold standard due to lower infection rates and better longevity, their long maturation time and high primary failure rate make substitutes necessary.

U.S. Arteriovenous Fistula Devices Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. arteriovenous fistula devices market report based on type and end-use.

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• AVF Creation Devices
  • Surgical Instruments
  • Vascular Grafts
  • Angioplasty Balloons
  • Others
• AVF Monitoring Devices
  • Doppler Ultrasound
  • Pressure Monitoring Systems
  • Others
• AVF Maintenance Devices
  • Central Venous Catheters
  • Stents
  • Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers
• Dialysis Centers

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of primary research
• 1.5. Information/Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type Outlook
  • 2.2.2. End Use Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Arteriovenous Fistula Devices Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. U.S. Arteriovenous Fistula Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework

Chapter 4. U.S. Arteriovenous Fistula Devices Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Arteriovenous Fistula Devices Market: Type Movement Analysis
• 4.3. U.S. Arteriovenous Fistula Devices Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.3.1. AVF Creation Devices
    • 4.3.1.1. AVF Creation Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.1.2. Surgical Instruments
      • 4.3.1.2.1. Surgical Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.1.3. Vascular Grafts
      • 4.3.1.3.1. Vascular Grafts Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.1.4. Angioplasty Balloons
      • 4.3.1.4.1. Angioplasty Balloons Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.1.5. Others
      • 4.3.1.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. AVF Monitoring Devices
    • 4.3.2.1. AVF Monitoring Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.2. Doppler Ultrasound
      • 4.3.2.2.1. Doppler Ultrasound Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.3. Pressure Monitoring Systems
      • 4.3.2.3.1. Pressure Monitoring Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.4. Others
      • 4.3.2.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.3. AVF Maintenance Devices
    • 4.3.3.1. AVF Maintenance Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3.2. Central Venous Catheters
      • 4.3.3.2.1. Central Venous Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3.3. Stents
      • 4.3.3.3.1. Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3.4. Others
      • 4.3.3.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Arteriovenous Fistula Devices Market: By End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Arteriovenous Fistula Devices Market: By End Use Movement Analysis
• 5.3. U.S. Arteriovenous Fistula Devices Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 5.3.1. Hospitals
    • 5.3.1.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3.2. Ambulatory Surgical Centers
    • 5.3.2.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3.3. Dialysis Centers
    • 5.3.3.1. Dialysis Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
• 6.3. Vendor Landscape
  • 6.3.1. Key company Heat Map Analysis, 2024
• 6.4. Company Profiles
  • 6.4.1. Medtronic
    • 6.4.1.1. Company Overview
    • 6.4.1.2. Financial Performance
    • 6.4.1.3. Product Benchmarking
    • 6.4.1.4. Strategic Initiatives
  • 6.4.2. BD
    • 6.4.2.1. Company Overview
    • 6.4.2.2. Financial Performance
    • 6.4.2.3. Product Benchmarking
    • 6.4.2.4. Strategic Initiatives
  • 6.4.3. Teleflex Incorporated
    • 6.4.3.1. Company Overview
    • 6.4.3.2. Financial Performance
    • 6.4.3.3. Product Benchmarking
    • 6.4.3.4. Strategic Initiatives
  • 6.4.4. Fresenius Medical Care
    • 6.4.4.1. Company Overview
    • 6.4.4.2. Financial Performance
    • 6.4.4.3. Product Benchmarking
    • 6.4.4.4. Strategic Initiatives
  • 6.4.5. B. Braun Medical Inc.
    • 6.4.5.1. Company Overview
    • 6.4.5.2. Financial Performance
    • 6.4.5.3. Product Benchmarking
    • 6.4.5.4. Strategic Initiatives
  • 6.4.6. Polymed
    • 6.4.6.1. Company Overview
    • 6.4.6.2. Financial Performance
    • 6.4.6.3. Product Benchmarking
    • 6.4.6.4. Strategic Initiatives
  • 6.4.7. Laminate Medical Technologies Ltd.
    • 6.4.7.1. Company Overview
    • 6.4.7.2. Financial Performance
    • 6.4.7.3. Product Benchmarking
    • 6.4.7.4. Strategic Initiatives
  • 6.4.8. Cook Group
    • 6.4.8.1. Company Overview
    • 6.4.8.2. Financial Performance
    • 6.4.8.3. Product Benchmarking
    • 6.4.8.4. Strategic Initiatives
  • 6.4.9. Smiths Group plc
    • 6.4.9.1. Company Overview
    • 6.4.9.2. Financial Performance
    • 6.4.9.3. Product Benchmarking
    • 6.4.9.4. Strategic Initiatives